Maria L. Ferrandiz
Av. Vicent A. Estellés S/n
Valencia, VC 46100, Spain
Valencia, VC 46100, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Dehydroisohispanolone alleviates NLRP3-driven inflammation in gout arthritis.
Journal: Biochemical pharmacology
Published: March 21, 2025
Hyaluronic Acid Hampers the Inflammatory Response Elicited by Extracellular Vesicles from Activated Monocytes in Human Chondrocytes.
Journal: Pharmaceutics
Published: August 29, 2024
Osteostatin Mitigates Gouty Arthritis through the Inhibition of Caspase-1 Activation and Upregulation of Nrf2 Expression.
Journal: International journal of molecular sciences
Published: December 31, 2023
Adenosine A2B receptor agonist improves epidermal barrier integrity in a murine model of epidermal hyperplasia.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 19, 2023
New Insights into the Pro-Inflammatory and Osteoclastogenic Profile of Circulating Monocytes in Osteoarthritis Patients.
Journal: International journal of molecular sciences
Published: December 18, 2023
Osteostatin Inhibits M-CSF+RANKL-Induced Human Osteoclast Differentiation by Modulating NFATc1.
Journal: International journal of molecular sciences
Published: June 23, 2022
Relevance of Nrf2 and heme oxygenase-1 in articular diseases.
Journal: Free radical biology & medicine
Published: September 30, 2019
Osteostatin Inhibits Collagen-Induced Arthritis by Regulation of Immune Activation, Pro-Inflammatory Cytokines, and Osteoclastogenesis.
Journal: International journal of molecular sciences
Published: July 26, 2019
Emerging therapeutic agents in osteoarthritis.
Journal: Biochemical pharmacology
Published: January 11, 2019
Nrf2 as a therapeutic target for rheumatic diseases.
Journal: Biochemical pharmacology
Published: February 15, 2018
Myeloid Heme Oxygenase-1 Regulates the Acute Inflammatory Response to Zymosan in the Mouse Air Pouch.
Journal: Oxidative medicine and cellular longevity
Published: June 29, 2017
Targeting inflammasome by the inhibition of caspase-1 activity using capped mesoporous silica nanoparticles.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: September 26, 2016
Last Updated: 09/26/2026